Stereotaxis
The AI engine Fit Assessment
BetaStereotaxis develops and applies robotic technologies in healthcare, particularly in surgical procedures for cardiac interventions.
Blurb
Stereotaxis develops robotic cardiology instrument navigation systems that enhances the treatment of arrhythmias and coronary diseases.
HQ Location
St. Louis (United States)
Founded
1990
Employees
51 - 200
Total funding raised
$166.50M
Funding Status
Post-IPO Equity, $50.00M, August 29, 2025
Subspaces
- Surgical Robotics
Pioneering Endovascular Robotics | Global leader in robotic technologies to enhance the treatment of arrhythmias & perform endovascular procedures